Showing 1521-1530 of 5827 results for "".
Combatting Disparities in Dermatology
https://practicaldermatology.com/topics/general-topics/combatting-disparities-in-dermatology/18338/Research shows disparities in dermatology exisit. Junko Takeshita, MD, PhD, MSCE discusses some examples, such as racial disaparities in which patients recieve biolgics to treat severe psoriasis. She also shares tips on how to determine what implicit biases you may have to race, gender, weight, etc.Avoid the Three Most Common Asset Protection Mistakes
https://practicaldermatology.com/topics/practice-management/avoid-the-three-most-common-asset-protection-mistakes/18368/OJM Group principal David Mandell, JD, MBA discusses the importance of protecting personal and business assets from lawsuits, and outlines strategies to avoid the three asset protection mistakes made by most doctors. Click here to request or download a free copy of Wealth Protection Planning for DeItching for Answers: Understanding and Treating Pruritus
https://practicaldermatology.com/topics/general-topics/itching-for-answers-understanding-and-treating-pruritus/18493/Since childhood, when he was affected by eczema and associated pruritus, Ethan Lerner, MD, PhD has been fascinated by itch, its causes, and its potential treatments. In this edition of Benchside Dispatches, he offers a fresh look at the latest research on pruritus and the challenges facing scientistAD Impact, Allofill Comes to Market, GPA Launches
https://practicaldermatology.com/topics/psoriasis/dermwiretv-ad-impact-allofill-comes-to-market-gpa-launches/18567/From sleep disruptions or negative impact on the ability to work to feelings of depression and anxiety, atopic dermatitis can have significant effects on adults, new research suggests. In fact, more than half of respondents to a Harris Poll say that AD has negatively impacted their daily lives. DoriPros and Cons of DTC Advertising
https://practicaldermatology.com/topics/practice-management/pros-and-cons-of-dtc-advertising/18569/Hilary Baldwin, MD and James Q. Del Rosso, DO sit down with Derm Insider Host Neal Bhatia, MD to weigh the pros and cons of direct-to-consumer advertising on patients. They agree that if done well and with a primary focus on disease state rather than a specific drug, these ads can encourage patientsFull-Face Rejuvenation: Surface to Shape
https://practicaldermatology.com/topics/general-topics/full-face-rejuvenation-surface-to-shape/18576/DermTube Journal Club host Nancy Samolitis, MD interviews Sabine Zenker, MD about her approach to full-face rejuvenation to address patients' concerns about changes on the surface of their skin to the structure. Dr. Zenker says facial rejuvenation needs to address skin quality, wrinkles and rhytids,Advocating for Dermatology
https://practicaldermatology.com/topics/practice-management/advocating-for-dermatology/18578/Host Neal Bhatia, MD sits down with two dermatologists with a great deal of experience advocating for the field — Terrence A. Cronin Jr, MD and Lawrence J. Green, MD. They share insights into how advocacy arms like SkinPAC and the Advisory Board committee of the American Academy of Dermatology work.Patient Outreach Initiatives; Erelzi Approved
https://practicaldermatology.com/topics/practice-management/dermwiretv-patient-outreach-initiatives-erelzi-approved---etudruli/18580/DermatologistOnCall® Partners with NPF to enhance access to care for psoriasis. Vivacare Partners with NRS for patient education. Erelzi from Sandoz approved as biosimilar to Enbrel. And the FDA bans antibacterial ingredients from hand soaps; Calls for plain soap and water hand washing.Topical Toxins: Now and Later
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-toxins-now-and-later/18768/Topical neurotoxins are in late-stage development, with the potential to offer "softer" results and reduction of fine wrinkles. But they may not be approved for another few years. In the meantime, micro channel delivery of toxins, such as with AquaGold, is an option. Joel Schlessinger, MD, founder oAcne Update: A Review of New Guidelines, Treatment Advances, and Drugs in the Pipeline
https://practicaldermatology.com/topics/general-topics/acne-update-a-review-of-new-guidelines-treatment-advances-and-drugs-in-the-pipeline/18773/Linda Stein Gold, MD talks to DermTube Journal Club Host Joshua Zeichner, MD about the new acne treatment guidelines recently published in the Journal of the American Academy of Dermatology. She discusses the process of developing the guidelines and highlights some of what's new, such as new, limite